NEW YORK (GenomeWeb News) – Accelerate Diagnostics today reported that revenues for its third quarter jumped 151 percent year over year.

Revenues for the three months ended Sept. 30 rose to $12,797 from $5,115 in the year-ago period "due to fluctuations in partner sales volumes on which royalties were due the company," Accelerate said in its quarterly earnings document filed with the US Securities and Exchange Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.